Do antioxidant vitamin and mineral supplements slow down the progression of age-related macular degeneration (AMD)?
Age-related macular degeneration is a progressive and sight-threatening disease affecting the central area of the retina at the back of the eye. There are Cochrane Reviews of the use of antioxidant vitamin and mineral supplements to prevent or slow down progression of the disease and the latter was updated in September 2023. Here ' s lead author, Jenny Evans from the London School of Hygiene and Tropical Medicine in the UK to tell us about the latest evidence. (Source: Podcasts from The Cochrane Library)
Source: Podcasts from The Cochrane Library - November 13, 2023 Category: General Medicine Authors: Cochrane Source Type: podcasts

JAMA Ophthalmology : Association of Dietary and Supplementary Calcium Intake With Age-Related Macular Degeneration
Interview with Emily Y. Chew, MD, author of Association of Dietary and Supplementary Calcium Intake With Age-Related Macular Degeneration: Age-Related Eye Disease Study Report 39 (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - March 21, 2019 Category: General Medicine Source Type: podcasts

Pravin U. Dugel, MD - Updates in Neovascular Age-Related Macular Degeneration: Improving Detection, Reducing the Burden of Treatment, and Optimizing Visual Outcomes
Updates in Neovascular Age-Related Macular Degeneration: Improving Detection, Reducing the Burden of Treatment, and Optimizing Visual Outcomes (Source: PeerView CME/CE Audio Podcast - Immunology)
Source: PeerView CME/CE Audio Podcast - Immunology - June 15, 2018 Category: Allergy & Immunology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts

Vitamins for Age-Related Macular Degeneration
A look at the evidence supporting vitamin therapy for the most common cause of vision loss in US adults: age-related macular degeneration. (Source: Medscape Ophthalmology Podcast)
Source: Medscape Ophthalmology Podcast - January 16, 2018 Category: Opthalmology Authors: Medscape Source Type: podcasts

Antioxidant vitamin and mineral supplements to prevent the development of age-related macular degeneration (AMD)
Age-related macular degeneration is a progressive and sight-threatening disease affecting the central area of the retina. Two updated Cochrane Reviews from July 2017 present the evidence for the use of antioxidant vitamin and mineral supplements to prevent it or slow down progression. Lead author, Jenny Evans from the London School of Hygiene and Tropical Medicine in the UK tells us more in this podcast.Note: the other Cochrane Reviews this podcast refers to isAntioxidant vitamin and mineral supplements to slow down the progression of age-related macular degeneration (AMD) (Source: Podcasts from The Cochrane Library)
Source: Podcasts from The Cochrane Library - October 11, 2017 Category: General Medicine Authors: Cochrane Source Type: podcasts

Antioxidant vitamin and mineral supplements to slow down the progression of age-related macular degeneration (AMD)
Age-related macular degeneration is a progressive and sight-threatening disease affecting the central area of the retina. Two updated Cochrane Reviews from July 2017 present the evidence for the use of antioxidant vitamin and mineral supplements to prevent it or slow down progression. Lead author, Jenny Evans from the London School of Hygiene and Tropical Medicine in the UK tells us more in this podcast.Note: the other Cochrane Reviews this podcast refers to isAntioxidant vitamin and mineral supplements to prevent the development of age-related macular degeneration (AMD) (Source: Podcasts from The Cochrane Library)
Source: Podcasts from The Cochrane Library - October 11, 2017 Category: General Medicine Authors: Cochrane Source Type: podcasts

Antioxidant vitamin and mineral supplements to slow down the progression of age-related macular degeneration (AMD)
Age-related macular degeneration is a progressive and sight-threatening disease affecting the central area of the retina. Two updated Cochrane Reviews from July 2017 present the evidence for the use of antioxidant vitamin and mineral supplements to prevent it or slow down progression. Lead author, Jenny Evans from the London School of Hygiene and Tropical Medicine in the UK tells us more in this podcast.The other Cochrane Review this podcast refers to can be found here:Antioxidant vitamin and mineral supplements to prevent the development of age-related macular degeneration (AMD) (Source: Podcasts from The Cochrane Library)
Source: Podcasts from The Cochrane Library - October 11, 2017 Category: General Medicine Authors: Cochrane Source Type: podcasts

Antioxidant vitamin and mineral supplements to prevent the development of age-related macular degeneration (AMD)
Age-related macular degeneration is a progressive and sight-threatening disease affecting the central area of the retina. Two updated Cochrane Reviews from July 2017 present the evidence for the use of antioxidant vitamin and mineral supplements to prevent it or slow down progression. Lead author, Jenny Evans from the London School of Hygiene and Tropical Medicine in the UK tells us more in this podcast.The other Cochrane Review this podcast refers to can be found here:Antioxidant vitamin and mineral supplements to slow down the progression of age-related macular degeneration (AMD) (Source: Podcasts from The Cochrane Library)
Source: Podcasts from The Cochrane Library - October 11, 2017 Category: General Medicine Authors: Cochrane Source Type: podcasts

JAMA Ophthalmology : Detecting Neovascular AMD When Visual Acuity Is Relatively Good
Interview with Allen C. Ho, MD, author of The Potential Importance of Detection of Neovascular Age-Related Macular Degeneration When Visual Acuity Is Relatively Good (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - January 19, 2017 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts

Detecting Neovascular AMD When Visual Acuity Is Relatively Good (JAMA Ophthalmology)
Interview with Allen C. Ho, MD, author of The Potential Importance of Detection of Neovascular Age-Related Macular Degeneration When Visual Acuity Is Relatively Good (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - January 19, 2017 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts

Associations Between Carotenoid Intake and AMD (JAMA Ophthalmology)
Interview with Juan Wu and Debra Schaumberg, MD, authors of Intakes of Lutein, Zeaxanthin, and Other Carotenoids and Age-Related Macular Degeneration During 2 Decades of Prospective Follow-up (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - October 8, 2015 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts

JAMA Ophthalmology : Associations Between Carotenoid Intake and AMD
Interview with Juan Wu and Debra Schaumberg, MD, authors of Intakes of Lutein, Zeaxanthin, and Other Carotenoids and Age-Related Macular Degeneration During 2 Decades of Prospective Follow-up (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - October 8, 2015 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts

Anti-vascular endothelial growth factor for neovascular age-related macular degeneration
Age-related macular degeneration is a major course of vision problems but recent years have seen the arrival of treatments that might not only slow vision loss, but reverse it. Sharon Solomon from the Wilmer Eye Institute at Johns Hopkins School of Medicine located in Baltimore USA describes the findings from the August 2014 update of the Cochrane Review examining the effects of a class of drugs that might help, the anti-vascular endothelial growth factors. (Source: Podcasts from The Cochrane Library)
Source: Podcasts from The Cochrane Library - March 6, 2015 Category: Journals (General) Authors: Cochrane Source Type: podcasts

Listen to The Lancet: 16 October
Robert Lanza discusses two-year follow-up findings of human embryonic stem-cell transplantation in the potential treatment of Stargardt’s Macular dystrophy and age-related macular degeneration. (Source: Listen to The Lancet)
Source: Listen to The Lancet - October 16, 2014 Category: Journals (General) Authors: The Lancet Source Type: podcasts

The Lancet: October 16, 2014
Robert Lanza discusses two-year follow-up findings of human embryonic stem-cell transplantation in the potential treatment of Stargardt's Macular dystrophy and age-related macular degeneration. (Source: Listen to The Lancet)
Source: Listen to The Lancet - October 16, 2014 Category: General Medicine Authors: The Lancet Source Type: podcasts